Cornwall Council voted 31 to 27 against a motion that would have barred looked-after children in Cornwall from participating in the PATHWAYS puberty blocker trial. Councillors who opposed the motion argued that existing safeguarding processes already covered the concern, that singling out gender identity care amounted to discrimination, and that the motion placed politicians between young people and their clinicians.

What the motion actually asked for

On Tuesday 22 July, Independent councillor Dulcie Tudor brought a motion to Cornwall Council's full meeting, seconded by Conservative councillor Martyn Alvey, asking the council to use its corporate parenting powers to prevent any looked-after child in Cornwall from joining the PATHWAYS trial. PATHWAYS is a clinical research study led by King's College London, investigating the effects of puberty-suppressing medication on under-16s with gender incongruence. It was commissioned specifically because routine prescribing was halted and critics demanded a proper evidence base. In other words, it is the research the sceptics asked for.

Cllr Tudor framed it carefully. She said it was not about national health policy, not about directing NHS practice, just about the council's responsibilities as corporate parent to the more than 600 looked-after children in Cornwall. She pointed to the over-representation of autistic young people and those who have experienced adverse childhood experiences among referrals to gender identity services, and argued that those vulnerabilities demanded extra protection.

On the surface, that sounds considered. But the argument underneath it is not. The claim that autistic or traumatised children who express a trans identity should therefore be steered away from affirming care rests on a chain of assumptions that does not hold up: that their trans identity is a symptom of their neurodivergence or their trauma rather than a real part of who they are, that waiting or withholding is neutral, and that a council vote is an appropriate substitute for clinical judgement. None of those assumptions are supported by the evidence, and the clinical framing here matters.

The vote and what it showed

What made this debate worth following was not the motion itself, but the quality of the opposition to it. Lib Dem councillor David Garrigan put the sharpest point directly: "If this was a clinical trial for cancer treatment, it's unlikely we'd be standing here arguing that council should have a veto over medical decisions." That is the test, and it is the right one. The moment a council singles out one area of medicine for political override, it is no longer acting as a safeguarding body, it is acting as a gatekeeper, and the gate is pointed at trans young people specifically.

Labour councillor Kate Ewert made a related point. As a parent, she said, she would apply the same standard of scrutiny to any clinical trial for her own children. Cornwall's looked-after children services already do exactly that. Cllr Hilary Frank, the Lib Dem cabinet member for children, confirmed that officers had said no child in Cornwall's care was currently participating in the trial, and they did not expect that to change, because the existing safeguarding framework already covers participation in clinical trials involving unproven treatments.

So the motion was not only discriminatory, it was redundant. The thing it claimed to provide was already there.

The framing that needs challenging

Cllr Tudor's argument, even charitably read, takes a group of children who are already among the most marginalised, children in local authority care who are autistic or who have experienced abuse and neglect, and uses their vulnerability as a reason to restrict rather than support their self-determination. The underlying logic is that these children cannot reliably know their own gender identity. That is not a protective instinct. It is a denial of agency presented in the language of care.

The data on co-occurrence of autism and gender diversity is real, and it deserves honest engagement. But the conclusion is not that autistic trans children are probably mistaken. The conclusion is that they need clinicians who understand both identities and can support them appropriately. Good clinical care for a young person is not simplified by removing one avenue of support: it is complicated by doing so.

Independent councillor James Ball said he was "disgusted" by the motion and called it anti-trans and an attack on the LGBTQ+ community. He is not wrong. The motion used the language of safeguarding while targeting a specific group for restrictions that no other group faces in comparable medical decisions.

Why the result matters

Thirty-one councillors in Cornwall looked at this motion and said no. Some of the opposition was procedural: the safeguard already exists, so the motion does nothing useful. But the more substantive argument, the one made by Cllr Garrigan and Cllr Ewert, was moral: you do not single out one category of child for political override on medical decisions without a reason that applies equally elsewhere. Gender identity is not that reason.

Trans young people in care are already in a precarious position. They are more likely to face rejection, instability, and a lack of adults who understand their needs. What they need from corporate parents is not a new barrier between them and clinical support. They need exactly what every looked-after child needs: adults who take their wellbeing seriously, who listen to clinicians, and who do not allow political noise to substitute for individual care.

The PATHWAYS trial exists because there are genuine questions to answer about puberty-suppressing medication in this age group. Answering those questions properly requires that the young people who might benefit are not systematically excluded from the research by local votes before it has even run. The trial has ethical oversight. It has clinical supervision. It has the informed consent process that any research involving children requires. A council chamber is not the right place to override all of that, and Cornwall's councillors, by a margin of four, agreed.

I hope other councils notice.

If there is a news story you would like me to cover then just let Sammy know.

Dr Helen Webberley is a gender specialist, medical educator, and founder of GenderGP. She writes about gender diversity, trans healthcare, and the lives of trans people and their families.